13-119
Showing 1 - 25 of 7,972
Hearing Protection Equipment in Occurence of Acute Acoustic
Completed
- Acoustic Trauma
- Questionnaire
-
Angers, France
- +6 more
Sep 12, 2022
Weight Loss Trial in United States (VK2735, Placebo)
Recruiting
- Weight Loss
- VK2735
- Placebo
-
Birmingham, Alabama
- +19 more
Sep 28, 2023
Type 2 Diabetes Trial (NPM-119 (exenatide implant), Bydureon BCise (exenatide extended release))
Not yet recruiting
- Type 2 Diabetes
- NPM-119 (exenatide implant)
- Bydureon BCise (exenatide extended release)
- (no location specified)
Jan 29, 2023
Osteoarthritis, Gonarthrosis Trial in Rio De Janeiro (Photomodulation Therapy, Control)
Not yet recruiting
- Osteoarthritis
- Gonarthrosis
- Photomodulation Therapy
- Control
-
Rio De Janeiro, BrazilHospital Glória D'Or
Jul 27, 2023
Crow's Feet Trial in Seoul (DKB-119)
Active, not recruiting
- Crow's Feet
- DKB-119
-
Seoul, Korea, Republic ofChungang-University Hospital
Aug 28, 2023
Healthy Volunteers Trial (ARGX-119, Placebo)
Not yet recruiting
- Healthy Volunteers
- ARGX-119
- Placebo
- (no location specified)
Jan 2, 2023
Advanced Solid Tumor Trial in Philadelphia (ATRN-119)
Not yet recruiting
- Advanced Solid Tumor
-
Philadelphia, PennsylvaniaJordan Center for Gynecologic Oncology at Penn Perelman Center f
Jun 29, 2022
Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (efgartigimod PH20 SC, prednisone)
Recruiting
- Pemphigus Vulgaris
- Pemphigus Foliaceus
- efgartigimod PH20 SC
- prednisone
-
Birmingham, Alabama
- +120 more
Dec 22, 2022
(SNPs) in Metalloproteinases Genes With Risk of Primary Knee
Recruiting
- Metalloproteinase SNPs -1575 G/A MMP-2, 836 A/G MMP-9 and -77 A/G MMP-13 and Risk for Developing Knee Osteoarthritis in Greek Population
- No intervention, Patients selection based on clinical symptoms and radiological imaging
-
Thessaloníki, Athens, Greece3rd Orthopedic Department , Pagageorgiou Hospital
Aug 17, 2022
Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)
Not yet recruiting
- Prostate Cancer
- DFMO
- +3 more
-
Baltimore, MarylandJohns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023
Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)
Recruiting
- Pemphigus Vulgaris
- Pemphigus Foliaceus
- efgartigimod PH20 SC
- +2 more
-
Birmingham, Alabama
- +130 more
Dec 22, 2022
Metastatic Triple Negative Breast Cancer Trial (pembrolizumab, capecitabine, eribulin)
Completed
- Metastatic Triple Negative Breast Cancer
- pembrolizumab
- +4 more
- (no location specified)
Nov 9, 2021
Obesity Trial in Phoenix (Hypertonic saline infusion, Water deprivation)
Completed
- Obesity
- Hypertonic saline infusion
- Water deprivation
-
Phoenix, ArizonaNIDDK, Phoenix
Jan 26, 2023
Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)
Completed
- Advanced Epithelial Ovarian
- +3 more
-
Basking Ridge, New Jersey
- +5 more
Mar 4, 2022
Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in United States (Live, attenuated, recombinant dengue serotypes 1, 2, 3,
Completed
- Dengue
- +3 more
- Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
- Yellow Fever
-
Alabaster, Alabama
- +6 more
Mar 15, 2022
Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (eculizumab)
Completed
- Neuromyelitis Optica
- Neuromyelitis Optica Spectrum Disorder
- eculizumab
-
Scottsdale, Arizona
- +68 more
Jul 25, 2022
Graft-versus-Host Disease, Immune System Disorders Trial in United States (Mycophenolate Mofetil, Placebo)
Completed
- Graft-versus-Host Disease
- Immune System Disorders
- Mycophenolate Mofetil
- Placebo
-
Duarte, California
- +35 more
Dec 7, 2022
Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)
Active, not recruiting
- Renal Cell Carcinoma
- Cabozantinib
- +3 more
-
La Jolla, California
- +159 more
Jan 23, 2023
Depressive Disorder, Depression, Depression, Postpartum Trial in United States (Ganaxolone, Placebo)
Heart Failure, Reduced Ejection Fraction Trial in Sassari (Virtual reality)
Not yet recruiting
- Heart Failure
- Reduced Ejection Fraction
- Virtual reality
-
Sassari, ItalyValentina Micheluzzi
Oct 30, 2023